Friday, April 4, 2025
HomeTagsBiopharmaceutical

biopharmaceutical

UCB to acquire Zogenix

Regulated information – Inside information – UCB announced that the companies have entered into a definitive agreement under which UCB would acquire Zogenix, Inc.,...

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid...

Halo Labs Launches New Instruments for Protein, Cell, and Gene Therapy Developers

Halo Labs, a life science instrumentation company developing tools for biologics researchers, announced that it has launched its latest products - Aura+™and Aura PTx™. Also...

SK Life Science Announces FDA Clearance of IND Application for Its Oncology Candidate.

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company, announced that the U.S. Food and Drug Administration...

Bold Therapeutics Extends South Korea Option Agreement for BOLD-100, a First-in-Class Anti-Resistance Therapeutic

Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, is pleased to announce an extension of the option agreement with an undisclosed publicly traded South...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics